- Home
- KROS vs GDEN Comparison
KROS vs GDEN Comparison
Compare KROS & GDEN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | KROS | GDEN |
|---|---|---|
| Founded | 2015 | N/A |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Biotechnology: Pharmaceutical Preparations | Services-Misc. Amusement & Recreation |
| Sector | Health Care | Consumer Discretionary |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 655.9M | 741.2M |
| IPO Year | 2020 | 1999 |
Fundamental Metrics
Financial Performance| Metric | KROS | GDEN |
|---|---|---|
| Price | $19.22 | $27.56 |
| Analyst Decision | Buy | Hold |
| Analyst Count | 9 | 5 |
| Target Price | $23.00 | ★ $32.25 |
| AVG Volume (30 Days) | ★ 365.3K | 264.5K |
| Earning Date | 02-25-2026 | 02-26-2026 |
| Dividend Yield | N/A | ★ 3.62% |
| EPS Growth | ★ N/A | N/A |
| EPS | ★ 1.57 | 0.20 |
| Revenue | $246,718,000.00 | ★ $643,485,000.00 |
| Revenue This Year | $6,924.79 | N/A |
| Revenue Next Year | N/A | $1.94 |
| P/E Ratio | ★ $12.19 | $135.40 |
| Revenue Growth | ★ 37798.31 | N/A |
| 52 Week Low | $9.12 | $19.57 |
| 52 Week High | $22.55 | $35.49 |
Technical Indicators
Market Signals| Indicator | KROS | GDEN |
|---|---|---|
| Relative Strength Index (RSI) | 49.60 | 50.54 |
| Support Level | $18.33 | $27.01 |
| Resistance Level | $19.67 | $28.18 |
| Average True Range (ATR) | 0.70 | 0.51 |
| MACD | -0.03 | 0.03 |
| Stochastic Oscillator | 70.37 | 53.14 |
Price Performance
Historical ComparisonAbout KROS Keros Therapeutics Inc.
Keros Therapeutics Inc is a clinical-stage biopharmaceutical company focused on the discovery, development, and commercialization of novel treatments for patients suffering from hematological, pulmonary, and cardiovascular disorders with high unmet medical needs. The company's protein therapeutic product candidate, KER-050, is being developed for the treatment of low blood cells counts, or cytopenias, including anemia and thrombocytopenia, in patients with myelodysplastic syndromes, or MDS, and in patients with myelofibrosis.
About GDEN Golden Entertainment Inc.
Golden Entertainment Inc is a U.S. based company that focuses on distributed gaming, casino, and resort operations. Its reportable segments are Nevada Casino Resorts, Nevada Locals Casinos, Nevada Taverns, and Distributed Gaming. The majority of the revenue for the company is generated from its Nevada Casino Resorts segment which is comprised of destination casino resort properties offering a variety of food and beverage outlets, entertainment venues, and other amenities.